Free Alerts   Login
Health Care › Pharmaceutical Preparations

ORGS Stock Price Correlated With Orgenesis Financials

ORGS Stock Price vs. Quarterly
ORGS
Income Statement
Cash Flow
Balance Sheet

ORGS Income Statement

Enable JavaScript and reload
Revenue, Net:
Revenue Per Share:
Cost of Goods & Services Sold:
Gross Profit:
Selling, General & Admin Expense:
Research & Development Expense:
Total Operating Expenses:
Operating Income:
Income Taxes:
Net Income:
Earnings Per Share, Diluted:
Earnings Per Share, Basic:
Shares Outstanding, Basic Avg:
Shares Outstanding, Diluted Avg:
Common Stock Shares Outstanding:

ORGS Cash Flow

Enable JavaScript and reload
Operating Activities Net Income:
Depreciation, Depletion & Amortization:
Change in Accounts Receiveable:
Net Cash from Operations:
Net Cash from Operations Per Share:
Repurchases/Buybacks Common Stock:
Issuance of Long-term Debt:
Cash Dividends Paid:
Net Cash from Financing Activities:
Property, Plant & Equipment Purchases:
Purchases of Businesses, Net of Cash:
Net Cash from Investing Activities:
Net Change in Cash & Equivalents:

ORGS Balance Sheet

Enable JavaScript and reload
Cash and Cash Equivalents:
Short-Term Investments:
Accounts Receivable, Net:
Inventories:
Total Current Assets:
Property, Plant & Equipment, Net:
Total Assets:
Accounts Payable:
Current Portion of Long-Term Debt:
Total Short-Term Liabilities:
Long Term Debt, Non-Current Portion:
Total Long-Term Liabilities:
Total Liabilities:

Insider Trading

 
Change
Value
Transaction
SEC Form 4
Safier Jacob   10% Owner
365,140 sh at $1
$213,280
Buy
Safier Jacob   10% Owner
10,100 sh at $0
$3,332
Buy

Free historical financial statements for Orgenesis Inc. See how revenue, income, cash flow, and balance sheet financials have changed over 28 quarters since 2017. Compare with ORGS stock chart to see long term trends.

Data imported from Orgenesis Inc SEC filings. Check original filings before making any investment decision.